ECR GLOBAL Trademark

Trademark Overview


On Friday, October 14, 2022, a trademark application was filed for ECR GLOBAL with the United States Patent and Trademark Office. The USPTO has given the ECR GLOBAL trademark a serial number of 97632503. The federal status of this trademark filing is REGISTERED as of Tuesday, September 3, 2024. This trademark is owned by Elixir Clinical Research Co.,Ltd.. The ECR GLOBAL trademark is filed in the Advertising, Business and Retail Services category with the following description:

Advertising relating to pharmaceutical products and in-vivo imaging products; Advertising services; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Rental of advertising space
ecr global

General Information


Serial Number97632503
Word MarkECR GLOBAL
Filing DateFriday, October 14, 2022
Status700 - REGISTERED
Status DateTuesday, September 3, 2024
Registration Number7496635
Registration DateTuesday, September 3, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 17, 2023

Trademark Statements


Description of MarkThe mark consists of the literal element "ECR Global" in stylized font along with a curved line above the letters "lobal".
Pseudo MarkELIXIR CLINICAL RESEARCH GLOBAL
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesAdvertising relating to pharmaceutical products and in-vivo imaging products; Advertising services; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Rental of advertising space
NOT AVAILABLE"GLOBAL"

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, October 31, 2022
Primary Code035
First Use Anywhere DateWednesday, March 1, 2023
First Use In Commerce DateWednesday, March 1, 2023

Trademark Owner History


Party NameElixir Clinical Research Co.,Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressShanghai 201103
CN

Party NameElixir Clinical Research Co.,Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressShanghai 201103
CN

Party NameElixir Clinical Research Co.,Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressShanghai 201103
CN

Trademark Events


Event DateEvent Description
Tuesday, October 18, 2022NEW APPLICATION ENTERED
Monday, October 31, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 1, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, July 29, 2023ASSIGNED TO EXAMINER
Friday, August 4, 2023PRIORITY ACTION WRITTEN
Friday, August 4, 2023PRIORITY ACTION E-MAILED
Friday, August 4, 2023NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, September 12, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 17, 2023PUBLISHED FOR OPPOSITION
Wednesday, September 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 26, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 20, 2024USE AMENDMENT FILED
Thursday, June 27, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, May 20, 2024TEAS STATEMENT OF USE RECEIVED
Monday, July 29, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, July 29, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 3, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, September 3, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED